| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals, Inc. (SNOA) has 6 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. SNOA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 42.2K | $51.0K | - | |
| CFO | 34.4K | $41.6K | - | |
| Other | 25.3K | $30.6K | - | |
| ? | 20.0K | $24.2K | - | |
| ? | 20.0K | $24.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2018 | Miller Robert E | Chief Financial Officer | Buy | 2,400 | $4.06 | $9,755.52 | +7.0% | |
| Mar 12, 2018 | Miller Robert E | Chief Financial Officer | Buy | 2,400 | $3.97 | $9,516.00 | +8.2% | |
| Mar 8, 2018 | Schutz James J | Chief Executive Officer | Buy | 2,473 | $3.99 | $9,867.27 | +7.4% | |
| Nov 30, 2017 | Schutz James J | Chief Executive Officer | Buy | 345 | $4.95 | $1,707.75 | +2.2% | |
| Nov 29, 2017 | Miller Robert E | Chief Financial Officer | Buy | 1,790 | $5.02 | $8,990.80 | +7.1% | |
| Nov 29, 2017 | Schutz James J | Chief Executive Officer | Buy | 400 | $5.03 | $2,012.00 | +2.6% | |
| Nov 24, 2017 | Schutz James J | Chief Executive Officer | Buy | 254 | $5.05 | $1,282.70 | +1.7% | |
| Nov 21, 2017 | Miller Robert E | Chief Financial Officer | Buy | 2,000 | $5.03 | $10,065.00 | +9.1% | |
| Aug 10, 2017 | Miller Robert E | Chief Financial Officer | Buy | 2,264 | $5.30 | $11,999.20 | +26.7% | |
| Aug 10, 2017 | Umscheid Marc | Chief Strategy/ Mkt Officer | Buy | 600 | $5.31 | $3,186.00 | +21.5% |